SummaryPurposeTo assess the prevalence and determinants of non-adherence to antiretroviral therapy (ART) as well as the concordance of two screening criteria in a major center for human immunodeficiency virus (HIV) treatment in Yaounde, Cameroon.MethodsIn 2011, we conducted a cross-sectional study involving a random sample of 889 adults (age>18 years, 67.9% women) infected with HIV who were receiving chronic care at the Yaounde Jamot Hospital. Adherence was assessed via self-administered questionnaires using the Community Programs for Clinical Research on AIDS (CPCRA) index and the Center for Adherence Support Evaluation (CASE) index.ResultsThe prevalence of non-adherence to ART was 22.5% based on the CPCRA index and 34.9% based on the CASE...
Background: Measurement of adherence to antiretroviral therapy (ART) can serve as a proxy for virolo...
BACKGROUND: Scale-up of antiretroviral therapy (ART) in resource-limited settings has drastically re...
Objectives The aim of this study was to describe clinical and virological outcomes in therapy-naive ...
SummaryPurposeTo assess the prevalence and determinants of non-adherence to antiretroviral therapy (...
Summary: Purpose: To assess the prevalence and determinants of non-adherence to antiretroviral ther...
Following global efforts to increase antiretroviral therapy (ART) access in Sub-Saharan Africa, ART ...
ObjectivesTo characterize antiretroviral therapy (ART) adherence across different programmes and exa...
Background: Acquired immunodeficiency syndrome (AIDS) caused by human immunodeficiency virus (HIV) i...
Background:Highly Active Antiretroviral Therapy (HAART) is undoubtedly the only proven remedy known ...
Since the early days of antiretroviral therapy, adherence has emerged a milestone to success. The ob...
Background: Generalizable data are needed on the magnitude and determinants of adherence and virolog...
Since the early days of antiretroviral therapy, adherence has emerged a milestone to success. The ob...
Background: According to UNAIDS 2019, 52% of people worldwide living with HIV is on antiretrovirals ...
Objective The rapid scale up of antiretroviral treatment (ART) in sub-Saharan Africa (SSA) has resul...
Magister Public Health - MPHAim: To obtain baseline data on adherence levels and the major determina...
Background: Measurement of adherence to antiretroviral therapy (ART) can serve as a proxy for virolo...
BACKGROUND: Scale-up of antiretroviral therapy (ART) in resource-limited settings has drastically re...
Objectives The aim of this study was to describe clinical and virological outcomes in therapy-naive ...
SummaryPurposeTo assess the prevalence and determinants of non-adherence to antiretroviral therapy (...
Summary: Purpose: To assess the prevalence and determinants of non-adherence to antiretroviral ther...
Following global efforts to increase antiretroviral therapy (ART) access in Sub-Saharan Africa, ART ...
ObjectivesTo characterize antiretroviral therapy (ART) adherence across different programmes and exa...
Background: Acquired immunodeficiency syndrome (AIDS) caused by human immunodeficiency virus (HIV) i...
Background:Highly Active Antiretroviral Therapy (HAART) is undoubtedly the only proven remedy known ...
Since the early days of antiretroviral therapy, adherence has emerged a milestone to success. The ob...
Background: Generalizable data are needed on the magnitude and determinants of adherence and virolog...
Since the early days of antiretroviral therapy, adherence has emerged a milestone to success. The ob...
Background: According to UNAIDS 2019, 52% of people worldwide living with HIV is on antiretrovirals ...
Objective The rapid scale up of antiretroviral treatment (ART) in sub-Saharan Africa (SSA) has resul...
Magister Public Health - MPHAim: To obtain baseline data on adherence levels and the major determina...
Background: Measurement of adherence to antiretroviral therapy (ART) can serve as a proxy for virolo...
BACKGROUND: Scale-up of antiretroviral therapy (ART) in resource-limited settings has drastically re...
Objectives The aim of this study was to describe clinical and virological outcomes in therapy-naive ...